Menu
GeneBe

3-63912635-C-T

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_001377405.1(ATXN7):c.37C>T(p.Pro13Ser) variant causes a missense change. The variant allele was found at a frequency of 0.000161 in 1,052,932 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00028 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00014 ( 1 hom. )

Consequence

ATXN7
NM_001377405.1 missense

Scores

2
3
10

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 5.69
Variant links:
Genes affected
ATXN7 (HGNC:10560): (ataxin 7) The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum, brain stem and spinal cord. Clinically, ADCA has been divided into three groups: ADCA types I-III. ADCAI is genetically heterogeneous, with five genetic loci, designated spinocerebellar ataxia (SCA) 1, 2, 3, 4 and 6, being assigned to five different chromosomes. ADCAII, which always presents with retinal degeneration (SCA7), and ADCAIII often referred to as the 'pure' cerebellar syndrome (SCA5), are most likely homogeneous disorders. Several SCA genes have been cloned and shown to contain CAG repeats in their coding regions. ADCA is caused by the expansion of the CAG repeats, producing an elongated polyglutamine tract in the corresponding protein. The expanded repeats are variable in size and unstable, usually increasing in size when transmitted to successive generations. This locus has been mapped to chromosome 3, and it has been determined that the diseased allele associated with spinocerebellar ataxia-7 contains 37-306 CAG repeats (near the N-terminus), compared to 4-35 in the normal allele. The encoded protein is a component of the SPT3/TAF9/GCN5 acetyltransferase (STAGA) and TBP-free TAF-containing (TFTC) chromatin remodeling complexes, and it thus plays a role in transcriptional regulation. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.006052196).
BS2
High AC in GnomAd at 41 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
ATXN7NM_001377405.1 linkuse as main transcriptc.37C>T p.Pro13Ser missense_variant 3/13 ENST00000674280.1
ATXN7NM_001177387.1 linkuse as main transcriptc.37C>T p.Pro13Ser missense_variant 2/13
ATXN7NM_000333.4 linkuse as main transcriptc.37C>T p.Pro13Ser missense_variant 3/13
ATXN7NM_001377406.1 linkuse as main transcriptc.37C>T p.Pro13Ser missense_variant 2/12

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
ATXN7ENST00000674280.1 linkuse as main transcriptc.37C>T p.Pro13Ser missense_variant 3/13 NM_001377405.1 P2O15265-1

Frequencies

GnomAD3 genomes
AF:
0.000277
AC:
41
AN:
148178
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00933
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000120
Gnomad OTH
AF:
0.000488
GnomAD3 exomes
AF:
0.000734
AC:
17
AN:
23168
Hom.:
0
AF XY:
0.000570
AC XY:
8
AN XY:
14024
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.0119
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000133
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000143
AC:
129
AN:
904754
Hom.:
1
Cov.:
30
AF XY:
0.000138
AC XY:
59
AN XY:
426774
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.000365
Gnomad4 ASJ exome
AF:
0.00689
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000763
Gnomad4 OTH exome
AF:
0.000461
GnomAD4 genome
AF:
0.000277
AC:
41
AN:
148178
Hom.:
0
Cov.:
32
AF XY:
0.000249
AC XY:
18
AN XY:
72208
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00933
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000120
Gnomad4 OTH
AF:
0.000488
ExAC
AF:
0.000486
AC:
10

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenSep 01, 2023- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.26
T
BayesDel_noAF
Benign
-0.37
Cadd
Uncertain
25
Dann
Uncertain
0.99
Eigen
Benign
-0.028
Eigen_PC
Benign
0.066
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Benign
0.49
T;T;T;T;.;.
M_CAP
Uncertain
0.10
D
MetaRNN
Benign
0.0061
T;T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationTaster
Benign
1.0
D;D;D;D
PrimateAI
Pathogenic
0.91
D
PROVEAN
Pathogenic
-8.0
D;.;N;N;N;.
REVEL
Benign
0.042
Polyphen
0.28, 0.56
.;.;B;P;B;P
Vest4
0.28, 0.26, 0.28
MutPred
0.31
Gain of phosphorylation at P13 (P = 0.0013);Gain of phosphorylation at P13 (P = 0.0013);Gain of phosphorylation at P13 (P = 0.0013);Gain of phosphorylation at P13 (P = 0.0013);Gain of phosphorylation at P13 (P = 0.0013);Gain of phosphorylation at P13 (P = 0.0013);
MVP
0.28
ClinPred
0.17
T
GERP RS
3.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.20
gMVP
0.36

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs557445610; hg19: chr3-63898311; API